Neochem Bio Solutions Limited (NSE:NEOCHEM)
India · Delayed Price · Currency is INR 91.35
+1.90 (2.12%)
At close: Jul 28, 2026
Neochem Bio Solutions Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 120.27 | 77.51 | 19.27 | 10.73 | - |
Depreciation & Amortization | 12.44 | 13.28 | 12.2 | 12.17 | - |
Loss (Gain) From Sale of Assets | 0.44 | -0.74 | - | - | - |
Other Operating Activities | 55.69 | 51.33 | 29.67 | 22.56 | - |
Change in Accounts Receivable | -234.47 | -80.36 | -25.77 | 9.57 | - |
Change in Inventory | -54.98 | -55.46 | -32.79 | -16.37 | - |
Change in Accounts Payable | -51.68 | 21.97 | 6.93 | -49.46 | - |
Change in Other Net Operating Assets | -38.32 | -1.56 | -15.82 | 3.38 | - |
Operating Cash Flow | -190.63 | 25.95 | -6.31 | -7.42 | - |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -25.46 | -11.41 | -83.85 | -33.3 | - |
Sale of Property, Plant & Equipment | - | - | 30.29 | - | - |
Investment in Securities | -62.5 | 0 | 0.89 | - | - |
Other Investing Activities | 22.55 | -5.46 | 0.04 | -0.21 | - |
Investing Cash Flow | -65.41 | -16.87 | -52.63 | -33.51 | - |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 61.4 | 18.75 | 56.63 | - |
Long-Term Debt Issued | - | - | 57.86 | 5.27 | - |
Total Debt Issued | - | 61.4 | 76.61 | 61.9 | - |
Short-Term Debt Repaid | -58.22 | -22.57 | - | -3.33 | - |
Long-Term Debt Repaid | -120.09 | -15.83 | - | - | - |
Total Debt Repaid | -178.31 | -38.39 | - | -3.33 | - |
Net Debt Issued (Repaid) | -178.31 | 23.01 | 76.61 | 58.57 | - |
Issuance of Common Stock | 470.65 | - | 20 | - | - |
Other Financing Activities | -35.05 | -35.05 | -34.65 | -20.99 | - |
Financing Cash Flow | 257.29 | -12.04 | 61.95 | 37.57 | - |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | 0.04 | -0 | - |
Net Cash Flow | 1.26 | -2.96 | 3.05 | -3.36 | - |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -216.08 | 14.54 | -90.16 | -40.72 | - |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -19.52% | 1.73% | -14.72% | -8.45% | - |
Free Cash Flow Per Share | -15.65 | 1.24 | -13.51 | -7.70 | - |
Levered Free Cash Flow | -267.01 | -31.12 | -87.73 | - | - |
Unlevered Free Cash Flow | -245.1 | -11.61 | -72.03 | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 35.05 | 35.05 | 29.59 | 21 | - |
Cash Income Tax Paid | 29.62 | 8.7 | - | 2.79 | - |
Change in Working Capital | -379.45 | -115.42 | -67.45 | -52.88 | - |